BioLife Solutions Inc. (BLFS)

13.26
0.09 0.68
NASDAQ : Health Technology
Prev Close 13.17
Open 13.17
Day Low/High 12.70 / 13.42
52 Wk Low/High 4.63 / 26.35
Volume 126.55K
Avg Volume 338.10K
Exchange NASDAQ
Shares Outstanding 15.11M
Market Cap 185.64M
EPS -0.20
P/E Ratio N/A
Div & Yield N.A. (N.A)

Latest News

BioLife Solutions To Ring NASDAQ Closing Bell On August 29, 2018

BioLife Solutions To Ring NASDAQ Closing Bell On August 29, 2018

BOTHELL, Wash., Aug.

Biolife Solutions Reaches Analyst Target Price

Biolife Solutions Reaches Analyst Target Price

In recent trading, shares of Biolife Solutions Inc have crossed above the average analyst 12-month target price of $20.00, changing hands for $20.81/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: downgrade on valuation, or, re-adjust their target price to a higher level.

BioLife Solutions Announces Second Quarter 2018 Financial Results

BioLife Solutions Announces Second Quarter 2018 Financial Results

Revenue increases 102% to $5.2 million. Net income of $1.0 million achieved

Casdin Capital Invests $20 Million In BioLife Solutions To Support Strategic Growth Opportunities

Casdin Capital Invests $20 Million In BioLife Solutions To Support Strategic Growth Opportunities

M&A Activities to Focus on Cell and Gene Manufacturing Tools

SAVSU Technologies Awarded New Patent For Cold Chain Technologies Used In Cell And Gene Therapies

SAVSU Technologies Awarded New Patent For Cold Chain Technologies Used In Cell And Gene Therapies

6 Additional Pending Patent Applications Submitted for evo Smart Shippers, Liquid Nitrogen Dry Vapor Shippers and Cold Chain SaaS Application

Sandler Capital Funds To Increase Shareholding In BioLife Solutions

Sandler Capital Funds To Increase Shareholding In BioLife Solutions

Investment Firm to Purchase Shares from Existing Holders

BLFS Crosses Above Average Analyst Target

BLFS Crosses Above Average Analyst Target

In recent trading, shares of Biolife Solutions Inc have crossed above the average analyst 12-month target price of $11.50, changing hands for $14.99/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: downgrade on valuation, or, re-adjust their target price to a higher level.

BioLife Solutions To Join Russell Microcap® Index

BioLife Solutions To Join Russell Microcap® Index

BOTHELL, Wash., June 11, 2018 /PRNewswire/ --  BioLife Solutions, Inc.

Biolife Solutions Reaches Analyst Target Price

Biolife Solutions Reaches Analyst Target Price

In recent trading, shares of Biolife Solutions Inc have crossed above the average analyst 12-month target price of $10.67, changing hands for $10.71/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: downgrade on valuation, or, re-adjust their target price to a higher level.

BioLife Solutions Announces Partial Redemption Of Series A Preferred Stock

Redemption reduces annual cash dividend payment by $106,000

BioLife Solutions Makes Investment In SAVSU Technologies To Support Growth And Capture Additional Regenerative Medicine Cold Chain Opportunities

SAVSU Realizing Expanded evo® Product Adoption by Leading Specialty Logistics Providers and Cell Therapy Manufacturers

Biolife Solutions Reaches Analyst Target Price

Biolife Solutions Reaches Analyst Target Price

In recent trading, shares of Biolife Solutions Inc have crossed above the average analyst 12-month target price of $5.75, changing hands for $5.81/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: downgrade on valuation, or, re-adjust their target price to a higher level.

BLFS Crosses Above Average Analyst Target

BLFS Crosses Above Average Analyst Target

In recent trading, shares of Biolife Solutions Inc have crossed above the average analyst 12-month target price of $5.08, changing hands for $5.29/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: downgrade on valuation, or, re-adjust their target price to a higher level.

Shark Bites: Drone Maker AeroVironment Lines Up for 'Doofus' Trade

Shark Bites: Drone Maker AeroVironment Lines Up for 'Doofus' Trade

An attractive pattern has formed for AVAV.

These 5 Stocks Under $10 Could Make You a Lot of Money

These 5 Stocks Under $10 Could Make You a Lot of Money

Here's a technical look at how to trade several under-$10 stocks that are within range of triggering big breakouts.

BioLife Solutions (BLFS) Is Strong On High Volume Today

BioLife Solutions (BLFS) Is Strong On High Volume Today

Trade-Ideas LLC identified BioLife Solutions (BLFS) as a strong on high relative volume candidate

BioLife Solutions (BLFS) Weak On High Volume

BioLife Solutions (BLFS) Weak On High Volume

Trade-Ideas LLC identified BioLife Solutions (BLFS) as a weak on high relative volume candidate

Strong On High Volume: BioLife Solutions (BLFS)

Strong On High Volume: BioLife Solutions (BLFS)

Trade-Ideas LLC identified BioLife Solutions (BLFS) as a strong on high relative volume candidate

BioLife Sciences (BLFS) Stock Spikes as Clinical Trial Meets Primary Endpoint

BioLife Sciences (BLFS) Stock Spikes as Clinical Trial Meets Primary Endpoint

BioLife Sciences (BLFS) shares are up over 60% to after customer TiGenix's clinical trial meets primary endpoint.

5 Stocks Under $10 Set to Soar -- Must-See Charts

5 Stocks Under $10 Set to Soar -- Must-See Charts

Here's a technical look at how to trade five stocks under $10 that look to be setting up to break out.

Sell These 7 Health Care Supplies Companies Now

Sell These 7 Health Care Supplies Companies Now

An aging population means the outlook is positive for health care equipment and supplies companies, but not every stock in the industry is a buy.

BioLife Solutions (BLFS) Stock Spiking to Reach One Year High

BioLife Solutions (BLFS) Stock Spiking to Reach One Year High

BioLife Solutions (BLFS) stock is surging after the company announced several new customer disclosures.

BioLife Solutions (BLFS) Stock Spikes Today on Preliminary Financial Results

BioLife Solutions (BLFS) Stock Spikes Today on Preliminary Financial Results

BioLife Solutions (BLFS) shares are up double digits after the company released preliminary financial results today.

TheStreet Quant Rating: C- (Hold)